-
Loading metrics
Open Access
Peer-reviewed
Research Article
ADH1C Ile350Val Polymorphism and Cancer Risk: Evidence from 35 Case–Control Studies
-
Yao Xue ,
Contributed equally to this work with: Yao Xue, Meilin Wang
Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯ -
Meilin Wang ,
Contributed equally to this work with: Yao Xue, Meilin Wang
Affiliations Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯ -
Dongyan Zhong,
Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯ -
Na Tong,
Affiliation Department of Occupational Medicine and Environmental Health, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯ -
Haiyan Chu,
Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
⨯ -
Xiaojing Sheng,
Affiliations Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯ -
Zhengdong Zhang
* E-mail: drzdzhang@gmail.com
Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Department of Molecular & Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China, Department of Occupational Medicine and Environmental Health, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China
⨯
ADH1C Ile350Val Polymorphism and Cancer Risk: Evidence from 35 Case–Control Studies
- Yao Xue,
- Meilin Wang,
- Dongyan Zhong,
- Na Tong,
- Haiyan Chu,
- Xiaojing Sheng,
- Zhengdong Zhang
- Published: May 18, 2012
- https://doi.org/10.1371/journal.pone.0037227